Having a latex allergy is no fun, but it can be a real challenge for health professionals who have to work with a wide ...

Retractable Technologies, Inc. (NYSA: RVP) recently made headlines by withdrawing its complaint in the United States Court of International Trade on January 8, 2025. The company issued a press release ...

Regeneron promotes EYLEA, Libtayo, and Dupixent at JPMorgan event while touting a pipeline that targets major disease areas.

Smart syringes redefine modern injection protocols through built-in safety features and automated monitoring. Heightened ...

We have tried and tested the best air purifiers for allergies to help shield your home from dust, pet dander, and other airborne allergens ― these are our top picks to invest in this winter.

Five years ago, a cluster of people in Wuhan, China, fell sick with a virus never before seen in the world. The germ didn't have a name, nor did the illness it would cause. It wound up setting off ...

A citrus allergy is rare, caused by a reaction to certain proteins found in citrus fruits like oranges, limes, and lemons. In some cases, you might have a true allergy in which citrus triggers a ...

Video allegedly shows Vanlandingham grabbing supplies and walking to the goat pens while holding a syringe-like item. She then allegedly straddles the goat before forcing the syringe into the goat ...

In a welcome move for many patients who have a fear of needles, latest research by the Indian Institute of Technology Bombay (IIT Bombay) promises a painless syringe experience for all kinds of ...

IIT Bombay has developed needle-free shock syringes for painless, safe drug delivery, offering hope for a future without injection-related trauma. Tested on rats, it outperformed traditional needles ...

Kiwi allergies can cause mild symptoms at first, but they can also get worse over time. Reactions may start with an itchy, tingly mouth, but later on cause stomach pains, rash, or trouble breathing.

Back to Healio Healio’s top FDA articles in ophthalmology this year included updates on the Vabsymo prefilled syringe, two new aflibercept biosimilars and an oral therapy for Stargardt disease.